Search

Your search keyword '"Cordes, L."' showing total 147 results

Search Constraints

Start Over You searched for: Author "Cordes, L." Remove constraint Author: "Cordes, L."
147 results on '"Cordes, L."'

Search Results

3. 1412P Immune changes after enzalutamide (Enza) is added to androgen-deprivation therapy (ADT) in first-line metastatic castration-resistant prostate cancer (mCRPC)

7. Resilience of the primary health care system - German primary care practitioners' perspectives during the early COVID-19 pandemic

8. P-133 Clinical responses in pancreaticobiliary cancer patients who received bintrafusp alfa (BA) or BA plus CXCR1/2 inhibitor (SX-682) plus CEA/MUC1-targted vaccine (CV301)

10. 957O Long-term follow-up of patients (pts) with human papillomavirus (HPV)–associated malignancies treated with bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1

11. 664P Final results from phase I trial of cabozantinib/nivolumab (CaboNivo) alone or with ipilimumab (CaboNivoIpi) and peripheral immunity in metastatic genitourinary (mGU) tumors

12. Barrieren und Förderfaktoren in der Primärversorgung während der COVID-19-Pandemie in Baden-Württemberg aus Sicht grundversorgender Ärzt*innen (PrimaryCovCare/'MWK Lessons learned COVID-19')

13. [Impact of the COVID-19 pandemic on outpatient physical therapy in Germany]

14. Heat Transfer by Impingement Cooling of Spur Gears

16. Impact of angiotensin II pathway inhibition on tumor response to anti PD(L)1 based therapy

17. 681P Clinical and immune responses to immunotherapy in biochemically recurrent (non-metastatic castration sensitive) prostate cancer (BCRpc)

18. 616MO Efficacy of BN-brachyury (BNVax) + bintrafusp alfa (BA) + N-803 in castration-resistant prostate cancer (CRPC): Results from a preliminary analysis of the Quick Efficacy Seeking Trial (QuEST1)

19. SO-28 A randomized phase II trial of mFOLFOX6-based standard of care alone or in combination with Ad-CEA vaccine plus avelumab in patients with previously untreated metastatic colorectal cancer

22. Intermittent short course enzalutamide in biochemically recurrent prostate cancer: Analysis of PSA recovery, testosterone levels and tolerability

24. Buccal midazolam and rectal diazepam for epilepsy

25. A phase I, open-label, multiple-ascending-dose trial to investigate the safety, tolerability, pharmacokinetics, biological, and clinical activity of M7824, a novel bifunctional fusion protein targeting the PD-L1 and TGF-β pathways, in patients with metastatic or locally advanced solid tumors

28. Permanent genetic resources added to Molecular Ecology Resources Database 1 october 2010-30 november 2010

31. Development and fabrication of improved Schottky power diodes

32. Development and fabrication of improved Schottky power diodes, phases I and II

33. High voltage power Schottky diodes

34. New process produces high-power Schottky diodes

36. Legionella bozemanii sp. nov. and Legionella dumoffii sp. nov.: Classification of two additional species of Legionella associated with human pneumonia.

39. Susceptibility of Pittsburgh pneumonia agent (Legionella micdadei) and other newly recognized members of the genus Legionella to nineteen antimicrobial agents

40. Legionnaires' disease outbreak at an Atlanta, Georgia, Country Club: evidence for spread from an evaporative condenser.

48. Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma.

49. [Kidney disease in antiphospholipid antibody syndrome].

50. Avelumab in Patients With Metastatic Colorectal Cancer.

Catalog

Books, media, physical & digital resources